Opportunity Information: Apply for PAR 15 328
Apply for PAR 15 328
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Ethical, Legal and Policy Issues in HIV Research with Key Populations (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242 Mental Health Research Grants 93.855 Allergy and Infectious Diseases Research 93.856 Microbiology and Infectious Diseases Research.
- This funding opportunity was created on Aug 10, 2015 and posted on Aug 10, 2015.
- Applicants must submit their applications by Sep 8, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments City or township governments Independent school districts Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) Others (see text field entitled Additional Information on Eligibility for clarification) County governments Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Private institutions of higher education Small businesses.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Ethical, Legal and Policy Issues in HIV Research with Key Populations (R01) opportunity (Funding Opportunity Number PAR 15 328) was a National Institutes of Health (NIH) discretionary grant program designed to support research that digs into the real-world ethical, legal, and policy problems that arise when conducting HIV-related research or delivering HIV-related health services with populations that are often stigmatized, criminalized, or otherwise placed at higher risk through structural barriers. The core purpose of the FOA was to encourage projects that do more than describe challenges in general terms; applicants were invited to analyze these challenges carefully and develop approaches to address them in ways that improve how research studies are designed and run, and how HIV programs are implemented in practice, including work related to HIV-associated comorbidities.
A defining feature of the announcement is its specific focus on “key populations,” meaning groups that often experience disproportionate HIV burden and heightened vulnerability due to social, legal, and political conditions. The FOA identified six key populations that proposals could focus on, whether individually or in combination: (1) men who have sex with men, (2) people who inject drugs, (3) people in prisons and other closed settings, (4) sex workers, (5) transgender people, and (6) adolescent girls and young women who are at high risk of acquiring HIV or who are living with HIV. The emphasis on these populations reflects the fact that ethical and legal issues are frequently intensified in contexts where individuals face stigma, discrimination, criminal exposure, surveillance, constraints on autonomy, or barriers to confidential and respectful care.
In terms of what kinds of projects NIH was looking for, the FOA explicitly encouraged both empirical and conceptual work. Empirical projects could include data-driven studies that document how laws, policies, institutional practices, or social pressures affect recruitment, informed consent, privacy and confidentiality, participant safety, retention, data sharing, or equitable access to benefits from research and programs. Conceptual projects could include rigorous ethical analysis and policy development efforts that clarify obligations and propose frameworks, guidance, or actionable recommendations to reduce harms and improve protections. Across both types, the unifying idea was that ethical, legal, and policy challenges should be treated as central scientific and implementation issues that can shape study validity, participant welfare, and the overall impact of HIV research and services.
The mechanism for funding was the NIH R01, which typically supports substantial, investigator-initiated research projects. The activity area was health, and the FOA was associated with CFDA numbers 93.242 (Mental Health Research Grants), 93.855 (Allergy and Infectious Diseases Research), and 93.856 (Microbiology and Infectious Diseases Research. No cost sharing or matching requirement was listed, meaning applicants were not expected to provide non-federal matching funds as a condition of the award.
Eligibility was broad and included many types of U.S. and non-U.S. organizations. Eligible applicants included for-profit organizations (other than small businesses), small businesses, nonprofit organizations (both with and without 501(c)(3) status), public and private institutions of higher education, and a range of government entities (state, county, city or township governments, independent school districts, special district governments, and public housing authorities/Indian housing authorities). The FOA also named additional eligible categories such as Historically Black Colleges and Universities, Hispanic-serving institutions, Tribal Colleges and Universities, Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions, federally recognized and other tribal governments and organizations, U.S. territories or possessions, faith-based or community-based organizations, regional organizations, eligible federal agencies, and non-domestic (foreign) entities. This wide eligibility matches the practical reality that ethical, legal, and policy questions in HIV work often require interdisciplinary teams and partnerships that may include universities, community organizations, health systems, and policy-focused institutions, sometimes across national boundaries.
Administratively, the FOA was posted on August 10, 2015, with an original and current closing date of September 8, 2018, and an archive date of October 9, 2018, indicating the opportunity is no longer open for new applications. The sponsoring agency was NIH, and the full announcement was available through the NIH grants policy/guide website. For access or technical issues related to the announcement, the contact listed was the NIH Office of Extramural Research (OER) webmaster (FBOWebmaster@OD.NIH.GOV).
Frequently Asked Questions (FAQs)
What is the title and funding opportunity number for this grant?
The opportunity is titled "The Ethical, Legal and Policy Issues in HIV Research with Key Populations (R01)" and the Funding Opportunity Number is PAR 15 328.
Who sponsored this funding opportunity?
The sponsoring agency was the National Institutes of Health (NIH).
What type of grant mechanism did this opportunity use?
This funding opportunity used the NIH R01 mechanism, which typically supports substantial, investigator-initiated research projects.
What is the main purpose of this FOA?
The purpose was to support research that examines real-world ethical, legal, and policy problems that arise when conducting HIV-related research or delivering HIV-related health services with key populations that may face stigma, criminalization, or structural barriers.
What does the FOA mean by "key populations"?
"Key populations" refers to groups that often experience disproportionate HIV burden and heightened vulnerability due to social, legal, and political conditions. The FOA emphasized that ethical and legal issues can be intensified where people face stigma, discrimination, criminal exposure, surveillance, constraints on autonomy, or barriers to confidential and respectful care.
Which key populations were specifically identified in the announcement?
The FOA identified six key populations that proposals could focus on individually or in combination:
- Men who have sex with men
- People who inject drugs
- People in prisons and other closed settings
- Sex workers
- Transgender people
- Adolescent girls and young women who are at high risk of acquiring HIV or who are living with HIV
What kinds of projects was NIH looking for under this FOA?
NIH encouraged both empirical and conceptual projects focused on ethical, legal, and policy issues that affect HIV research and HIV-related health services with key populations, including work related to HIV-associated comorbidities.
What counts as an empirical project under this FOA?
Empirical projects could include data-driven studies documenting how laws, policies, institutional practices, or social pressures affect topics such as recruitment, informed consent, privacy and confidentiality, participant safety, retention, data sharing, or equitable access to benefits from research and programs.
What counts as a conceptual project under this FOA?
Conceptual projects could include rigorous ethical analysis and policy development efforts that clarify obligations and propose frameworks, guidance, or actionable recommendations to reduce harms and improve protections.
Did NIH want projects that only describe challenges in general terms?
No. The FOA emphasized that projects should go beyond general description by carefully analyzing ethical, legal, and policy challenges and developing approaches to address them in ways that improve how research studies are designed and run and how HIV programs are implemented in practice.
Why were ethical, legal, and policy issues treated as central scientific or implementation issues?
Because the FOA framed these issues as factors that can shape study validity, participant welfare, and the overall impact of HIV research and services.
What was the activity area for this funding opportunity?
The activity area was health.
Which CFDA numbers were associated with this FOA?
The FOA was associated with the following CFDA numbers:
- 93.242 (Mental Health Research Grants)
- 93.855 (Allergy and Infectious Diseases Research)
- 93.856 (Microbiology and Infectious Diseases Research)
Was cost sharing or matching required?
No. The FOA did not list a cost sharing or matching requirement, meaning applicants were not expected to provide non-federal matching funds as a condition of award.
Who was eligible to apply?
Eligibility was broad and included many types of U.S. and non-U.S. organizations, including for-profit organizations (other than small businesses), small businesses, nonprofit organizations (with or without 501(c)(3) status), public and private institutions of higher education, and a range of government entities.
What types of government entities were eligible?
Eligible government applicants included state governments, county governments, city or township governments, independent school districts, special district governments, and public housing authorities/Indian housing authorities.
Were specific institution types and community-focused organizations eligible?
Yes. The FOA explicitly named eligibility for organizations such as Historically Black Colleges and Universities, Hispanic-serving institutions, Tribal Colleges and Universities, Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions, federally recognized and other tribal governments and organizations, U.S. territories or possessions, and faith-based or community-based organizations, among others.
Were non-U.S. (foreign) entities allowed to apply?
Yes. The FOA included non-domestic (foreign) entities as eligible applicants.
When was this FOA posted?
The FOA was posted on August 10, 2015.
What was the application closing date?
The original and current closing date listed was September 8, 2018.
Is this funding opportunity still open?
No. The FOA shows an archive date of October 9, 2018, indicating the opportunity is no longer open for new applications.
Where was the full announcement available?
The full announcement was available through the NIH grants policy/guide website.
Who was listed as the contact for access or technical issues?
For access or technical issues related to the announcement, the listed contact was the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same category: Health
Next opportunity: NOTICE OF INTENT TO AWARD Commemorate the Boston Massacre through Blood on the Snow, a museum theater piece at Old State House with related educational programs
Previous opportunity: Lagoon Monitoring in Arctic Network parks
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 15 328
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 15 328) also looked into and applied for these:
| Funding Opportunity |
|---|
| A National Coalition to Enhance STD/HIV Prevention through Promotion of a Holistic Approach to Health and Wellness Apply for CDC RFA PS11 111205CONT15 Funding Number: CDC RFA PS11 111205CONT15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Short term Measurements of Improved Physical and Molecular Resilience in Pre clinical Models (R01) Apply for RFA AG 16 006 Funding Number: RFA AG 16 006 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| USAID/GHANA PEOPLE FOR HEALTH Apply for RFA 641 15 000009 Funding Number: RFA 641 15 000009 Agency: Ghana USAID Accra Category: Health Funding Amount: $3,710,000 |
| Centers of Research Translation (P50) Apply for RFA AR 16 001 Funding Number: RFA AR 16 001 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Strengthening HIV/AIDS Continuum of Care Services Apply for RFA 641 15 000010 Funding Number: RFA 641 15 000010 Agency: Ghana USAID Accra Category: Health Funding Amount: $18,500,000 |
| Nonhuman Primate Reagent Resource (U24) Apply for RFA AI 15 038 Funding Number: RFA AI 15 038 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| A Data Analysis and Coordinating Center (DACC) for Research Training and Career Development Activities (U24) Apply for RFA HG 15 025 Funding Number: RFA HG 15 025 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improving Health and Reducing Cardiometabolic Risk in Youth with Serious Emotional Disturbance and Young Adults with Severe Mental Illness (R01) Apply for RFA MH 16 600 Funding Number: RFA MH 16 600 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Nucleic Acid Sequencing Technology Development (R43/R44) Apply for RFA HG 15 033 Funding Number: RFA HG 15 033 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) (U19) Apply for PAR 15 330 Funding Number: PAR 15 330 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Impact Evaluation of Combination HIV Prevention Intervention in Botswana under PEPFAR Apply for RFA GH 16 002 Funding Number: RFA GH 16 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $8,729,606 |
| Strengthening and Expanding HIV/AIDS Surveillance, Prevention, Care and Support Services Targeting Vulnerable Populations in Ho Chi Minh City, Vietnam Apply for CDC RFA PS10 101705CONT16 Funding Number: CDC RFA PS10 101705CONT16 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Partnering with the Ministry of Health of Vietnam to Build a Sustainable System for HIV/AIDS Prevention, Care, and Treatment in the Socialist Republic of Vietnam under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 130403CONT16 Funding Number: CDC RFA GH13 130403CONT16 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Novel Nucleic Acid Sequencing Technology Development (R01) Apply for RFA HG 15 032 Funding Number: RFA HG 15 032 Agency: National Institutes of Health Category: Health Funding Amount: $700,000 |
| Novel Nucleic Acid Sequencing Technology Development (R21) Apply for RFA HG 15 031 Funding Number: RFA HG 15 031 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Limited Competition Alzheimers Disease Neuroimaging Initiative, ADNI (U19) Apply for RFA AG 16 019 Funding Number: RFA AG 16 019 Agency: National Institutes of Health Category: Health Funding Amount: $12,000,000 |
| Immunization and Vaccines for Children Program Apply for CDC RFA IP13 130104CONT16 Funding Number: CDC RFA IP13 130104CONT16 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| PPHF 2015 Immunization Utilization of Immunization Information Systems (IIS) for Assessment, Feedback, Apply for CDC RFA IP15 1505PPHF15 Funding Number: CDC RFA IP15 1505PPHF15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $450,000 |
| Health and Hygiene Activity Apply for RFA 367 15 000002 Funding Number: RFA 367 15 000002 Agency: Nepal USAID Kathmandu Category: Health Funding Amount: $5,000,000 |
| World Health Organization Expanding Efforts and Strategies to Prevent and Control TB Including Multidrug Resistant TB, and TB in Vulnerable Populations Apply for CDC RFA PS14 141202CONT16 Funding Number: CDC RFA PS14 141202CONT16 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 15 328", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.